Manuscripts
Showing 1533 manuscripts.
Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era.
Citation
Michael T. Brady, James M. Oleske, Paige L. Williams, Carol Elgie, Lynne M. Mofenson, Wayne M. Dankner, Russell B. Van Dyke. Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era.. Journal of Acquired Immune Deficiency Syndromes. 2010. 53: 86-94. PMID: 20035164Year
2010
Journal
Journal of Acquired Immune Deficiency Syndromes
T cell responses of HIV-infected children after administration of inactivated or live attenuated influenza vaccines
Citation
Adriana Weinberg, Lin-Ye Song, Robert Walker, Maria Allende, Terence Fenton, Sharon Appelbaum Nachman, Jennifer S. Read, Julie A. Patterson, Myron Levin. T cell responses of HIV-infected children after administration of inactivated or live attenuated influenza vaccines. AIDS Research and Human Retroviruses. 2010. 26: 51-9. PMID: 20059397Year
2010
Journal
AIDS Research and Human Retroviruses
Study
P1057
Safety and Immunogenicity of a Quadrivalent Human Papillomavirus [Types 6, 11, 16, 18] Vaccine in HIV-Infected Children 7 TO 12 Years Old
Citation
Myron Levin, Anna-Barbara Moscicki, Lin-Ye Song, Terence Fenton, Emily Demske, William A. Meyer, Barbara Nowak, Carlos A. Sattler, Alfred J. Saah, David Radley, Mark T. Esser, Adriana Weinberg. Safety and Immunogenicity of a Quadrivalent Human Papillomavirus [Types 6, 11, 16, 18] Vaccine in HIV-Infected Children 7 TO 12 Years Old. Journal of Acquired Immune Deficiency Syndromes. 2010. 55: 197-204. PMID: 20574412Year
2010
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
P1047
Directly Observed Therapy (DOT) for Non-adherent HIV Infected Youth - Lessons Learned, Challenges Ahead
Citation
Aditya Gaur, Marvin Eric Belzer, Paula Britto, Patricia A. Garvie, ChengCheng Hu, Bobbie L. Graham, Michael N. Neely, George D. McSherry, Stephen A. Spector, Patricia M. Flynn. Directly Observed Therapy (DOT) for Non-adherent HIV Infected Youth - Lessons Learned, Challenges Ahead. AIDS Research and Human Retroviruses. 2010. 26: 947-53. PMID: 20707731Year
2010
Journal
AIDS Research and Human Retroviruses
Study
P1036B
Associations of Proinflammatory Cytokine Levels With Lipid Profiles, Growth, and Body Composition in HIV-Infected Children Initiating or Changing Antiretroviral Therapy
Citation
Joseph S. Cervia, Caroline J. Chantry, Michael Hughes, Carmelita Alvero, William A. Meyer, Janice Hodge, Peggy R. Borum, John ( Jack ) Moye, Stephen A. Spector. Associations of Proinflammatory Cytokine Levels With Lipid Profiles, Growth, and Body Composition in HIV-Infected Children Initiating or Changing Antiretroviral Therapy. Pediatric Infectious Disease Journal. 2010. 29: 1118-1122. PMID: 20631646Year
2010
Journal
Pediatric Infectious Disease Journal
Study
P1010
Analytical and Biological Considerations in the Measurement of Cell-Associated CCR5 and CXCR4 mRNA and Protein
Citation
Denise Campbell, J. P. Lai, Nancy Tustin, Eric Riedel, Richard Tustin, Jeff Taylor, J. Edward Murray, Steven D. Douglas. Analytical and Biological Considerations in the Measurement of Cell-Associated CCR5 and CXCR4 mRNA and Protein. Clinical and Vaccine Immunology. 2010. 17: 1148-1154. PMID: 20463101Year
2010
Journal
Clinical and Vaccine Immunology
Identification of Ongoing Human Immunodeficiency Virus Type 1 (HIV-1) Replication in Residual Viremia during Recombinant HIV-1 Poxvirus Immunizations in Patients with Clinically Undetectable Viral Loads on Durable Suppressive Highly Active Antiretroviral
Citation
Carlum Shiu, Coleen K. Cunningham, Thomas C. Greenough, Petronella Muresan, Victor Sanchez Merino, Vincent J. Carey, Brooks Jackson, Carrie Ziemniak, Lawrence Fox, Marvin Eric Belzer, Stuart C. Ray, Katherine Luzuriaga, Deborah Persaud. Identification of Ongoing Human Immunodeficiency Virus Type 1 (HIV-1) Replication in Residual Viremia during Recombinant HIV-1 Poxvirus Immunizations in Patients with Clinically Undetectable Viral Loads on Durable Suppressive Highly Active Antiretroviral. Journal of Virology. 2010. 83: 9731-42.Year
2010
Journal
Journal of Virology
Study
P1059
Treatment with recombinant growth hormone is associated with modest improvement in CD4 lymphocyte reconstitution in HIV-infected persons on antiretroviral therapy: results of ACTG A5174
Citation
Vicki Stocker, Richard B. Pollard, Kimberly Y. Smith, Lu (Summer) Zheng, Ronald J. Bosch, David M. Margolis, Allan R. Tenorio, Laura A. Napolitano, Michael Switow Saag, Elizabeth Connick, Jody Lawrence, Barry H. Gross, Issac R. Francis, Hernan Valdez, Rui Wang, Norma Muurahainen. Treatment with recombinant growth hormone is associated with modest improvement in CD4 lymphocyte reconstitution in HIV-infected persons on antiretroviral therapy: results of ACTG A5174. AIDS Research and Human Retroviruses. 2010. 26: 425-432.Year
2010
Journal
AIDS Research and Human Retroviruses
Comparison of immunologic assays for detecting immune responses in HIV immunotherapeutic studies: AIDS clinical trials group trial A5181
Citation
Bernard J.C. Macatangay, Lu (Summer) Zheng, Charles Rinaldo, Alan Landay, Richard B. Pollard, Savita G. Pahwa, Michael M. Lederman, R. Pat Bucy. Comparison of immunologic assays for detecting immune responses in HIV immunotherapeutic studies: AIDS clinical trials group trial A5181. Clinical and Vaccine Immunology. 2010. 17: 1452-9. PMID: 20631337Year
2010
Journal
Clinical and Vaccine Immunology
Three-year safety and efficacy of vicriviroc, a CCR5 antagonist, in HIV-1-infected treatment-experienced patients.
Citation
Timothy J. Wilkin, Zhaohui Su, Amy Krambrink, Jianmin Long, Wayne Greaves, Robert Gross, Michael Hughes. Three-year safety and efficacy of vicriviroc, a CCR5 antagonist, in HIV-1-infected treatment-experienced patients.. Journal of Acquired Immune Deficiency Syndromes. 2010. 54: 470-6. PMID: 20672447Year
2010
Journal
Journal of Acquired Immune Deficiency Syndromes